Testing effectiveness (Phase 2)WithdrawnNCT05216614
What this trial is testing
Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia
Who this might be right for
COVID-19Olfactory DisorderParosmia
Washington University School of Medicine